ClinicalTrials.gg
Drug

Clindamycin clinical trials

Also written Dalacin C.

Includes 16 studies of Clindamycin phosphate.

studies test it
106
open now
15
in phase 3
25
first study started
2002

How each study uses Clindamycin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Clindamycin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
22 Feb 1970 · CLEOCIN HYDROCHLORIDE · NDA 050162 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Clindamycin
41
Cleocin
7
Clindamycin 300 mg capsule
2
Clindamycin 600 mg
2
Clindamycin 1% Gel
2

Brand

Dalacin C
2

In one entry with another drug

Given together, or one or the other

clindamycin/benzoyl peroxide gel
2
clindamycin and benzoyl peroxide
2

Studies by the year they started

103 studies that test it; most in 2009 (12)

Studies that test Clindamycin, by start year
YearStudies
20021
20032
20055
20062
20072
20085
200912
20107
20111
20125
201310
20145
20157
20162
20174
20187
20193
20204
20212
20222
20233
20246
20251
20265

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
11
Phase 2
15
Phase 3
25
Phase 4
40
No phase
19

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 34 · Other 72

Stiefel, a GSK Company (10) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · Taro Pharmaceuticals USA (3) · GlaxoSmithKline (3) · Teva Pharmaceuticals USA (2) · Padagis LLC (2) · Michael Cohen-Wolkowiez (2) · Lumara Health, Inc. (2)

Often tested with

Tested in the same studies.

Benzoyl Peroxide (15) · Cefazolin (8) · Trimethoprim, Sulfamethoxazole Drug Combination (6) · Amoxicillin (6) · Ampicillin (5) · Gentamicins (5) · Doxycycline (5) · Levofloxacin (4)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6

Studies that test Clindamycin.

Studies

Open first, then newest update. How each study uses Clindamycin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 106

See all 106 studies that test Clindamycin →

Given beside what is tested · 7 — Clindamycin is usual care or a partner of the new treatment
As the comparator · 19 — what is tested is compared with Clindamycin

Codes

What other systems call Clindamycin · ClinicalTrials.gg INT007228

  • MeSH (NLM) D002981ClindamycinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 3U02EL437CCLINDAMYCINConfirmed FDA, NLM, Wikidata
  • RxNorm 2582Confirmed FDA, Wikidata
  • Wikidata Q422273clindamycinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C377ClindamycinOne source FDA
  • DrugBank DB01190One source Wikidata

Also registered as clindamycin hydrochloride (UNII T20OQ1YN1W · RxNorm 81982).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.